Thursday, 15 October 2026European Markets

REC SILICON Stock Bullish Momentum With A 9.46% Rise On Thursday

Loading stream...

(VIANEWS) - The Market ended the session with REC SILICON (RECSI.OL) rising 9.46% to kr10.78 on Thursday, following the last session's upward trend. Oslo Børs Benchmark Index_GI jumped 0.04% to kr1,274.52, following the last session's downward trend on what was a somewhat bullish trend trading session today.

REC SILICON's last close was kr9.85, 47.61% under its 52-week high of kr18.80.

About REC SILICON

REC Silicon ASA, together with its subsidiaries, produces and sells silicon materials for the solar and electronics industries worldwide. It offers various solar grade polysilicon for solar applications, including NextSi used for multi crystalline and monocrystalline solar ingot and wafer production in the manufacturing of solar modules. The company provides electronic grade polysilicon comprising Float Zone based devices that are used in motor control and power conversion processes for hybrid and electric vehicles, wind energy, and high voltage transmission, 5G communications, high-speed trains, Internet of Things, and big data; and Czochralski, an electronic grade polysilicon that principally used in manufacturing of semiconductor wafers. In addition, it offers silicon gases consisting of silane, dichlorosilane, monochlorosilane, and disilane. The company was formerly known as Renewable Energy Corporation ASA and changed its name to REC Silicon ASA in October 2013. REC Silicon ASA was founded in 1996 and is headquartered in Lysaker, Norway.

Earnings Per Share

As for profitability, REC SILICON has a trailing twelve months EPS of kr-2.54.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 44.59%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

REC SILICON's EBITDA is -453.21.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is 50.6% and 66.7%, respectively.

More news about REC SILICON (RECSI.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com